Date published: 2026-3-31

1-800-457-3801

SCBT Portrait Logo
Seach Input

OR8H2 Inhibitors

OR8H2 belongs to the olfactory receptor family, a diverse collection of G-protein-coupled receptors that play a critical role in odor detection and the sensory perception of smell. These receptors are characterized by their ability to bind to a wide range of volatile chemical compounds, each receptor typically recognizing specific molecular features. OR8H2, like other olfactory receptors, is predominantly expressed in the sensory neurons of the olfactory epithelium. The expression of olfactory receptors such as OR8H2 is a highly regulated process, involving a complex interplay of genetic and epigenetic factors that ensure a precise and narrowly-tuned response to olfactory signals. The modulation of OR8H2 expression can be of interest in various fields of research, particularly those exploring the intricate mechanisms that govern the sense of smell and the cellular processes underlying olfactory function. Several chemical compounds have been identified that could potentially inhibit the expression of OR8H2, each through distinct molecular mechanisms. For instance, histone deacetylase inhibitors like Trichostatin A may indirectly lead to the repression of OR8H2 expression by altering chromatin structure in a way that is less conducive to gene transcription. Similarly, compounds that affect DNA methylation patterns, such as 5-Azacytidine, could decrease OR8H2 expression by causing epigenetic changes that silence gene activity. Transcriptional inhibitors like Actinomycin D bind directly to DNA, impeding the transcriptional machinery and thereby reducing OR8H2 mRNA levels. On the translational level, inhibitors like Cycloheximide and Anisomycin interfere with ribosomal function, thus preventing the proper synthesis of the OR8H2 protein. Additional compounds, such as Mitomycin C and Puromycin, exert their effects on gene expression by interacting with DNA replication or by mimicking aminoacyl-tRNAs, respectively, leading to flawed protein synthesis. Collectively, these chemicals represent a spectrum of molecules that can provide insight into the various stages and pathways through which the expression of genes like OR8H2 can be reduced or inhibited at both transcriptional and translational stages.

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$152.00
$479.00
$632.00
$1223.00
$2132.00
33
(3)

Trichostatin A could potentially lead to hyperacetylation of histones at the promoter region of the OR8H2 gene, which might repress transcription initiation, thereby decreasing OR8H2 expression.

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

By inhibiting DNA methyltransferase, 5-Azacytidine could demethylate CpG islands near the OR8H2 gene, potentially leading to the recruitment of repressive complexes and downregulation of OR8H2.

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$74.00
$243.00
$731.00
$2572.00
$21848.00
53
(3)

Actinomycin D binds to guanine-rich regions of DNA, potentially blocking the transcriptional elongation process of the OR8H2 gene, leading to a decrease in OR8H2 mRNA and protein levels.

α-Amanitin

23109-05-9sc-202440
sc-202440A
1 mg
5 mg
$269.00
$1050.00
26
(2)

α-Amanitin could specifically bind to and inhibit RNA polymerase II, leading to the suppression of mRNA synthesis for OR8H2, resulting in a reduced translation of the OR8H2 protein.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

Rapamycin binds to FKBP12 and forms a complex that inhibits mTORC1, potentially leading to a decreased initiation of cap-dependent translation, reducing the synthesis of the OR8H2 protein.

Cycloheximide

66-81-9sc-3508B
sc-3508
sc-3508A
100 mg
1 g
5 g
$41.00
$84.00
$275.00
127
(6)

Cycloheximide could block the translocation step in protein synthesis on ribosomes, which would prevent the elongation of the nascent OR8H2 polypeptide, effectively inhibiting OR8H2 protein synthesis.

Anisomycin

22862-76-6sc-3524
sc-3524A
5 mg
50 mg
$99.00
$259.00
36
(2)

Anisomycin could inhibit peptidyl transferase activity on ribosomes, halting the extension of the polypeptide chain and thereby halting the production of OR8H2 protein.

Emetine

483-18-1sc-470668
sc-470668A
sc-470668B
sc-470668C
1 mg
10 mg
50 mg
100 mg
$440.00
$900.00
$1400.00
$2502.00
(0)

Emetine could inhibit the translocation of the ribosome along mRNA, thereby terminating protein elongation prematurely, which would include the synthesis of the OR8H2 protein.

Puromycin dihydrochloride

58-58-2sc-108071
sc-108071B
sc-108071C
sc-108071A
25 mg
250 mg
1 g
50 mg
$42.00
$214.00
$832.00
$66.00
394
(16)

Puromycin could cause the release of incomplete peptide chains by acting as an analog of aminoacyl-tRNA, which would result in the inhibition of full-length OR8H2 protein synthesis.

Mitomycin C

50-07-7sc-3514A
sc-3514
sc-3514B
2 mg
5 mg
10 mg
$66.00
$101.00
$143.00
85
(5)

Mitomycin C may form DNA adducts and cross-links within the OR8H2 gene, which could obstruct the transcription machinery, leading to a substantial decrease in OR8H2 expression.